Pre-emptive treatment with fibrinogen concentrate for postpartum haemorrhage: Randomized controlled trial

British Journal of Anaesthesia

Volumn 114, Issue 4, 2015, Pages 623-633

  Wikkelso A J ^a   Edwards, H M ^a   Afshari, A ^a   Stensballe, J ^b   Langhoff Roos, J ^a   Albrechtsen, C ^a   Ekelund, K ^a   Hanke, G ^a   Secher, E L ^a   Sharif, H F ^a   Pedersen, L M ^a   Troelstrup, A ^a   Lauenborg, J ^a   Mitchell, A U ^a   Fuhrmann, L ^a   Svare, J ^a   Madsen, M G ^a   Bodker B ^a   Moller A M ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Rigshospitalet ^*  (Denmark)

Author keywords

blood coagulation; erythrocyte transfusion; fibrinogen; postpartum haemorrhage

Indexed keywords

FIBRINOGEN CONCENTRATE; HEMOGLOBIN; SODIUM CHLORIDE;

ADULT; ARTICLE; BLOOD TRANSFUSION; BODY WEIGHT; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; ERYTHROCYTE TRANSFUSION; FEMALE; HUMAN; INTENTION TO TREAT ANALYSIS; MAJOR CLINICAL STUDY; MATERNAL MORTALITY; MULTICENTER STUDY; POSTPARTUM HEMORRHAGE; PREMEDICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; TREATMENT OUTCOME;

EID: 84964285924     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aeu444     Document Type: Article

References (30)

1. Fleming D, Gangopadhyay R, Karoshi M, Arulkumaran S. Maternal deaths from major obstetric hemorrhage in the UK: changing evidence from the confidential enquiries (1985-2011). In: Arulkumaran S, Karoshi M, Keith LG, Lalonde AB, B-Lynch C, eds. AComprehensive Textbook of Postpartum Hemorrhage: An Essential Clinical Reference for Effective Management, 2nd Edn. London, UK: 2012; 162-8
2. Lowe GDO, Rumley A, Mackie IJ. Plasma fibrinogen. Ann Clin Biochem 2004; 41: 430-40
3. Abbassi-Ghanavati M, Greer LG, Cunningham FG. Pregnancy and laboratory studies: a reference table for clinicians. Obstet Gynecol 2009; 114: 1326-31
4. Charbit B, Mandelbrot L, Samain E, et al. The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. J Thromb Haemost 2007; 5: 266-73
5. Gayat E, Resche-Rigon M, Morel O, et al. Predictive factors of advanced interventional procedures in a multicentre severe postpartum haemorrhage study. Intensive Care Med 2011; 37: 1816-25
6. Cortet M, Deneux-Tharaux C, Dupont C, et al. Association between fibrinogen level and severity of postpartum haemorrhage: secondary analysis of a prospective trial. Br J Anaesth 2012; 108: 984-9
7. Poujade O, Zappa M, Letendre I, Ceccaldi PF, Vilgrain V, Luton D. Predictive factors for failure of pelvic arterial embolization for postpartum hemorrhage. Int J Gynaecol Obstet 2012; 117: 119-23
8. Wikkelsø A, Lunde J, Johansen M, et al. Fibrinogen concentrate in bleedingpatients.CochraneDatabase SystRev2013;8:CD008864
9. Butwick AJ. Postpartum hemorrhage and low fibrinogen levels: the past, present and future. Int J Obstet Anesth 2013; 22: 87-91
10. Wikkelsoe AJ, Afshari A, Stensballe J, et al. The FIB-PPH trial: fibrinogen concentrate as initial treatment for postpartum haemorrhage: study protocol for a randomised controlled trial. Trials 2012; 13: 110
11. Danish Society of Obstetrics and Gynecology, Danish Society of Anesthesiology and Intensive Care Medicine. Danish Postpartum Haemorrhage Guidelines 2013. Available fromhttp://www.dsog. dk/files/postpartum-bloedning.pdf (accessed 15 January 2014)
12. RiaSTAP official FDA information 2009. Available from http://www .drugs.com/pro/riastap.html (accessed 15 January 2014)
13. The Capital Region Blood Bank. Resuscitation Guidelines-transfusion with blood components, 2007. Available from http://www. regionh.dk/NR/rdonlyres/B4720A2F-2CB0-453A-A7D8-1DA208D DB455/0/Rigshospitaletfolder.pdf (accessed 15 January 2014)
14. Danish Health and Medicines Authority. Guidelines on transfusion of allogenic blood products, 2007. Available from http://www. dasaim.dk/wp-content/uploads/2014/02/vejledn-om-blodtrans fusion.pdf (accessed 15 January 2014)
15. Carroli G, Cuesta C, Abalos E, Gulmezoglu AM. Epidemiologyof postpartum haemorrhage: a systematic review. Best Pract Res Clin Obstet Gynaecol 2008; 22: 999-1012
16. Royal College of Obstetricians and Gynaecologists. Clinical Governance Advice No. 6a, 2010. Available from https://www.rcog.org.uk/ en/guidelines-research-services/guidelines/clinical-governanceadvice-6/ (assessed 5 Dec 2014)
17. Virkus RA, Løkkegaard ECL, Lidegaard Ø, et al. Venous thromboembolism in pregnancy and the puerperal period: a study of 1210 events. Acta Obstet Gynecol Scand 2013; 92: 1135-42
18. Karlsson M, TernströmL, Hyllner M, et al. Prophylactic fibrinogen infusion reduces bleedingafter coronaryarterybypass surgery.Aprospective randomised pilot study. Thromb Haemost 2009; 102: 137-44
19. Fenger-Eriksen C, Jensen TM, Kristensen BS, et al. Fibrinogen substitution improves whole blood clot firmness after dilution with hydroxyethyl starch in bleeding patients undergoing radical cystectomy: a randomized, placebo-controlled clinical trial. J Thromb Haemost 2009; 7: 795-802
20. Sørensen B, Asvaldsdottir HS, Gudmundsdottir BR, Onundarson PT. The combination of recombinant factor VIIa and fibrinogen correct clotting ex vivo in patient samples obtained following cardiopulmonary bypass surgery. Thromb Res 2009; 124: 695-700
21. De Lloyd L, Bovington R, Kaye A, et al. Standard haemostatic tests following major obstetric haemorrhage. Int J Obstet Anesth 2011; 20: 135-41
22. Bonnet M-P, Deneux-Tharaux C, Dupont C, Rudigoz R-C, Bouvier-Colle M-H. Transfusion practices in postpartum hemorrhage: a population-based study. Acta Obstet Gynecol Scand 2013; 92: 404-13
23. Girard T, Mörtl M, Schlembach D.Newapproaches to obstetric hemorrhage: the postpartum hemorrhage consensus algorithm. Curr Opin Anaesthesiol 2014; 27: 267-74
24. Levy JH,Welsby I, Goodnough LT. Fibrinogen as atherapeutic target for bleeding: a review of critical levels and replacement therapy. Transfusion 2014; 54: 1389-405; quiz 1388
25. Chauleur C, Cochery-Nouvellon E, Mercier E, et al. Analysis of the venous thromboembolic risk associated with severe postpartum haemorrhage in the NOHA First cohort. Thromb Haemost 2008; 100: 773-9
26. Bell SF, Rayment R, Collins PW, Collis RE. The use of fibrinogen concentrate to correct hypofibrinogenaemia rapidly during obstetric haemorrhage. Int J Obstet Anesth 2010; 19: 218-23
27. Glover NJ, Collis RE, Collins P. Fibrinogen concentrate use during major obstetric haemorrhage. Anaesthesia 2010; 65: 1229-30
28. Bonnet M-P, Deneux-Tharaux C, Bouvier-Colle M-H. Critical care and transfusion management in maternal deaths from postpartum haemorrhage. Eur J Obstet Gynecol Reprod Biol 2011; 158: 183-8
29. Ahmed S, Harrity C, Johnson S, et al. The efficacy of fibrinogen concentratecompared with cryoprecipitate in majorobstetrichaemorrhage-an observational study. Transfus Med 2012; 22: 344-9
30. Kikuchi M, Itakura A, Miki A, Nishibayashi M, Ikebuchi K, Ishihara O. Fibrinogen concentrate substitution therapy for obstetric hemorrhage complicated by coagulopathy. J Obstet Gynaecol Res 2013; 39: 770-6